NorthStar Asset Management (Massachusetts)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.2M | Buy |
18,992
+27
| +0.1% | +$14.5K | 2.82% | 15 |
|
2025
Q1 | $7.96M | Buy |
18,965
+122
| +0.6% | +$51.2K | 2.36% | 18 |
|
2024
Q4 | $7.79M | Sell |
18,843
-61
| -0.3% | -$25.2K | 2.05% | 23 |
|
2024
Q3 | $9.55M | Buy |
18,904
+158
| +0.8% | +$79.8K | 2.35% | 20 |
|
2024
Q2 | $9.13M | Buy |
18,746
+386
| +2% | +$188K | 2.33% | 20 |
|
2024
Q1 | $9.91M | Sell |
18,360
-255
| -1% | -$138K | 1.74% | 20 |
|
2023
Q4 | $10.3M | Sell |
18,615
-108
| -0.6% | -$59.9K | 2.99% | 15 |
|
2023
Q3 | $8.19M | Buy |
18,723
+12
| +0.1% | +$5.25K | 2.62% | 18 |
|
2023
Q2 | $9.4M | Buy |
18,711
+239
| +1% | +$120K | 2.77% | 16 |
|
2023
Q1 | $9.24M | Sell |
18,472
-2,259
| -11% | -$1.13M | 2.84% | 16 |
|
2022
Q4 | $8.46M | Buy |
20,731
+67
| +0.3% | +$27.3K | 2.82% | 16 |
|
2022
Q3 | $6.73M | Buy |
20,664
+486
| +2% | +$158K | 2.33% | 18 |
|
2022
Q2 | $7.08M | Sell |
20,178
-2,498
| -11% | -$876K | 2.33% | 19 |
|
2022
Q1 | $12.4M | Buy |
22,676
+1,554
| +7% | +$850K | 3.4% | 12 |
|
2021
Q4 | $13.9M | Buy |
21,122
+676
| +3% | +$445K | 3.5% | 11 |
|
2021
Q3 | $12.7M | Buy |
20,446
+398
| +2% | +$248K | 3.36% | 12 |
|
2021
Q2 | $12.7M | Buy |
20,048
+1,232
| +7% | +$778K | 3.38% | 9 |
|
2021
Q1 | $9.21M | Buy |
+18,816
| New | +$9.21M | 2.9% | 14 |
|